June 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 3.75 billion in 2025 with a CAGR of 15.48%.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
April 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
March 2026
The global periodontal disease treatment market size was evaluated at USD 2.94 billion in 2025 and is predicted to hit around USD 6.23 billion by 2035, growing at a CAGR of 7.80%.
January 2026
The cellulite treatment market size was reached at USD 2.40 billion in 2025 and it is expected to surpass around USD 7.42 billion by 2035 with a CAGR of 10.72%.
January 2026
The global fabry disease treatment market size reached USD 2.45 billion in 2025 and is estimated to hit around USD 5.20 billion by 2035 with a CAGR of 7.82%.
December 2025
The chronic obstructive pulmonary disease treatment market size is expected to hit around USD 33.03 billion by 2035 from USD 21.04 billion in 2025 at a CAGR of 5.14%.
July 2025
The global hearing loss disease treatment market reached USD 14.43 billion in 2024 and is projected to surpass around USD 24.03 billion by 2034 with a CAGR of 5.23%.
June 2025
The global peripheral arterial disease treatment market size is estimated to hit around USD 6.11 billion by 2034 from USD 2.95 billion in 2024, with a CAGR of 7.56%.
August 2025
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%.
July 2025
The global respiratory antiviral treatment market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2025 to 2034.
July 2025
Explore the single dose gene therapy market as one-time treatments redefine the future of genetic disorder management and patient care.
June 2025
The global plasma protein therapeutics market size is projcetd to cross around USD 48.43 billion by 2034 from USD 29.56 billion in 2024 with a CAGR of 5.06%.
July 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
June 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global nasal polyposis treatment market size is evaluated at USD 5.27 billion in 2025 and is predicted to hit around USD 9.69 billion by 2035, growing at a CAGR of 6.28%.
June 2026
The global extracellular vesicles-based liquid biopsy market size is evaluated at USD 122.72 million in 2025 and is predicted to hit around USD 152.88 million by 2035, growing at a CAGR of 2.47%.
June 2026
The global cellulose-reinforced hydrogels market size is evaluated at USD 1.44 billion in 2025 and is predicted to hit around USD 2.78 billion by 2035, growing at a CAGR of 6.80%.
June 2026
The ear nose throat (ENT) treatment market size was estimated to hit around USD 35.15 billion by 2035 increasing from USD 19.96 billion in 2025, with a CAGR of 5.82%.
June 2026
The asthma treatment market size accounted for USD 28.96 billion in 2025 and is expected to hit around USD 36.8 billion by 2035, poised to grow at a CAGR of 2.42%.
June 2026
The US glioblastoma multiforme treatment market size was evaluated at USD 789.54 million in 2025 and is predicted to hit around USD 1,634.84 million by 2035, growing at a CAGR of 7.55%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global minimal residual disease (MRD) testing market size is estimated to hit around USD 5.19 billion by 2035 increasing from USD 1.70 billion in 2025, with a CAGR of 11.81%.
June 2026
The global peripheral blood mononuclear cells market size was evaluated at USD 317.35 billion in 2025 and is predicted to hit around USD 842.89 billion by 2035, growing at a CAGR of 10.26%.
June 2026
The global acne treatment market size was valued at USD 12.37 billion in 2025 and is expected to hit around USD 20.99 billion by 2035, growing at a CAGR of 5.60%.
June 2026
The US cell and gene therapy market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 20.00 billion by 2035, growing at a CAGR of 17.21%.
June 2026
The global cell encapsulation technology market is growing as regenerative medicine and cell therapies adopt protective encapsulation techniques.
June 2026
The global natural killer (NK) cell therapeutics market size was evaluated at USD 477.10 million in 2025 and is predicted to hit around USD 12,316.96 million by 2035, growing at a CAGR of 38.42%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com